The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Alterations of the Notch pathway in lung cancer
Open accessAbstract
Notch signaling regulates cell specification and homeostasis of stem cell compartments, and it is counteracted by the cell fate determinant Numb. Both Numb and Notch have been implicated in human tumors. Here, we show that Notch signaling is altered in approximately one third of non–small-cell lung carcinomas (NSCLCs), which are the leading cause of cancer-related deaths: in ≈30% of NSCLCs, loss of Numb expression leads to increased Notch activity, while in a smaller fraction of cases (around 10%), gain-of-function mutations of the NOTCH-1 gene are present. Activation of Notch correlates with poor clinical outcomes in NSCLC patients without TP53 mutations. Finally, primary epithelial cell cultures, derived from NSCLC harboring constitutive activation of the Notch pathway, are selectively killed by inhibitors of Notch (γ-secretase inhibitors), showing that the proliferative advantage of these tumors is dependent upon Notch signaling. Our results show that the deregulation of the Notch pathway is a relatively frequent event in NSCLCs and suggest that it might represent a possible target for molecular therapies in these tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,715
Somatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
Herbst, R. S., Heymach, J. V., & Lippman, S. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0802714 · Cited by 2,389
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Reedijk, M., Odorcic, S., Chang, L., Zhang, H., Miller, N., McCready, D. R., Lockwood, G., & Egan, S. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1069 · Cited by 783
Tumor surveillance via the ARF–p53 pathway
Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.19.2984 · Cited by 717
The Hes gene family: repressors and oscillators that orchestrate embryogenesis
Kageyama, R., Ohtsuka, T., & Kobayashi, T. (2007) · Development · doi:10.1242/dev.000786 · Cited by 644
The INK4A/ARF locus and its two gene products.
Sharpless, N. E., & DePinho, R. A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80004-5 · Cited by 533
Mechanisms of asymmetric cell division: flies and worms pave the way
Gönczy, P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2388 · Cited by 489
Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis
Pece, S., Serresi, M., Santolini, E., Capra, M., Hulleman, E., Galimberti, V., Zurrida, S., Maisonneuve, P., Viale, G., & Di Fiore, P. P. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200406140 · Cited by 483
Self-citationγ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
Real, P. J., Tosello, V., Palomero, T., Castillo, M., Hernando, E., de Stanchina, E., Sulis, M. L., Barnes, K., Sawai, C., Homminga, I., et al. (2009) · Nature Medicine · doi:10.1038/nm.1900 · Cited by 445
Notch Signaling, γ-Secretase Inhibitors, and Cancer Therapy
Shih, I.-M., & Wang, T.-L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3958 · Cited by 421
Calcium Depletion Dissociates and Activates Heterodimeric Notch Receptors
Rand, M. D., Grimm, L. M., Artavanis-Tsakonas, S., Patriub, V., Blacklow, S. C., Sklar, J., & Aster, J. C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1825-1835.2000 · Cited by 408
NUMB controls p53 tumour suppressor activity
Colaluca, I. N., Tosoni, D., Nuciforo, P., Senic-Matuglia, F., Galimberti, V., Viale, G., Pece, S., & Di Fiore, P. P. (2008) · Nature · doi:10.1038/nature06412 · Cited by 385 · cited 15×
“From our studies in breast cancer and in tumor cell lines, loss of NUMB expression can confer a proliferative advantage through two mechanisms: (i) lack of counteraction over Notch (16), and (ii) increased degradation of the tumor suppressor TP53 (17).”
BackgroundMethodCell and molecular biology of Notch
Fiúza, U.-M., & Arias, A. M. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0242 · Cited by 371
Mammary Stem Cells and Breast Cancer—Role of Notch Signalling
Farnie, G., & Clarke, R. B. (2007) · Stem Cell Reviews · doi:10.1007/s12015-007-0023-5 · Cited by 356
Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis
Pharoah, P. D. P., Day, N. E., & Caldas, C. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690628 · Cited by 308
Epidermal Notch signalling: differentiation, cancer and adhesion
Watt, F. M., Estrach, S., & Ambler, C. A. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.010 · Cited by 295
The multifaceted role of Notch in cancer
Roy, M., Pear, W. S., & Aster, J. C. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.001 · Cited by 293
Aster, J. C., Pear, W. S., & Blacklow, S. C. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154300 · Cited by 266
γ-Secretase Inhibitor Prevents Notch3 Activation and Reduces Proliferation in Human Lung Cancers
Konishi, J., Kawaguchi, K. S., Vo, H., Haruki, N., Gonzalez, A., Carbone, D. P., & Dang, T. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1022 · Cited by 253
Roegiers, F., & Jan, Y. N. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.02.010 · Cited by 223
Lung cancer epigenetics and genetics
Risch, A., & Plass, C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23605 · Cited by 220
Lewis, H. D., Leveridge, M., Strack, P. R., Haldon, C., O’Neil, J., Kim, H., Madin, A., Hannam, J. C., Look, A. T., Kohl, N. E., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.12.010 · Cited by 164
McCann, A. H., Kirley, A., Carney, D. N., Corbally, N., Magee, H. M., Keating, G., & Dervan, P. A. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.189 · Cited by 140
Silva, J., Silva, J. M., Domínguez, G., García, J. M., Cantos, B., Rodríguez, R., Larrondo, F. J., Provencio, M., España, P., & Bonilla, F. (2003) · The Journal of Pathology · doi:10.1002/path.1297 · Cited by 116
Distinct Biological Roles for the Notch Ligands Jagged-1 and Jagged-2
Choi, K. C., Ahn, Y., Gibbons, D. L., Tran, H. T., Creighton, C. J., Girard, L., Minna, J. D., Qin, F. X.-F., & Kurie, J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003111 · Cited by 61
Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer
Silva, J., Domínguez, G., Silva, J. M., García, J. M., Gallego, I., Corbacho, C., Provencio, M., España, P., & Bonilla, F. (2001) · Oncogene · doi:10.1038/sj.onc.1204617 · Cited by 54
γ-secretase inhibitors: Notch so bad
Grosveld, G. C. (2009) · Nature Medicine · doi:10.1038/nm0109-20 · Cited by 42
Vestey, S. B., Sen, C., Calder, C. J., Perks, C. M., Pignatelli, M., & Winters, Z. (2004) · Breast Cancer Research · doi:10.1186/bcr912 · Cited by 21
Lee, S., Jung, C. K., Ko, Y. H., Choi, J. Y., Lee, K. Y., & Kang, C. S. (2008) · Basic and Applied Pathology · doi:10.1111/j.1755-9294.2008.00020.x · Cited by 10
Cited by
Non-small-cell lung cancers: a heterogeneous set of diseases
Chen, Z., Fillmore, C. M., Hammerman, P. S., Kim, C. F., & Wong, K.-K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3775 · Cited by 1,942
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
Agrawal, N., Frederick, M. J., Pickering, C. R., Bettegowda, C., Chang, K., Li, R. J., Fakhry, C., Xie, T.-X., Zhang, J., Wang, J., et al. (2011) · Science · doi:10.1126/science.1206923 · Cited by 1,697
Notch signaling pathway: architecture, disease, and therapeutics
Zhou, B., Lin, W., Long, Y., Yang, Y., Zhang, H., Wu, K., & Chu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00934-y · Cited by 1,114
Notch Signaling in Development, Tissue Homeostasis, and Disease
Siebel, C., & Lendahl, U. (2017) · Physiological Reviews · doi:10.1152/physrev.00005.2017 · Cited by 978
Notch signaling: simplicity in design, versatility in function
Andersson, E. R., Sandberg, R., & Lendahl, U. (2011) · Development · doi:10.1242/dev.063610 · Cited by 950
Metadata
- Authors
- Westhoff, B., Colaluca, I. N., D'Ario, G., Donzelli, M., Tosoni, D., Volorio, S., Pelosi, G., Spaggiari, L., Mazzarol, G., Viale, G., Pece, S., & Di Fiore, P. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-12-29
- Volume
- 106
- Issue
- 52
- Pages
- 22293-22298
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2146949185
- Cited by
- 387
- References
- 31
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.